Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:October 6, 2020Withdrawn
Hide Studies Not Open or Pending
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:October 6, 2020Withdrawn
Condition(s):Nonalcoholic Fatty Liver Disease (NAFLD)Last Updated:August 16, 2019Unknown status
Condition(s):Fatty Liver DiseaseLast Updated:December 12, 2019Unknown status
Condition(s):Hepatic Steatosis; Fatty LiverLast Updated:June 15, 2023Completed
Condition(s):Fatty LiverLast Updated:December 24, 2010Completed
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:January 23, 2023Recruiting
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:January 30, 2024Recruiting
Condition(s):Fatty LiverLast Updated:January 10, 2024Enrolling by invitation
Condition(s):Metabolic Associated Fatty Liver DiseaseLast Updated:June 22, 2023Recruiting
Condition(s):Non-alcoholic Fatty Liver Disease NAFLDLast Updated:July 1, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.